홈 > 시장보고서 > 식품/음료 > 건강보조식품

시장보고서

상품코드

1719902

세계의 할랄 의약품 시장 : 시장 규모, 점유율, 동향, 산업 분석 : 의약품별, 제형별, 치료 영역별, 인증 유형별, 최종사용자별, 지역별 - 시장 예측(2025-2034년)

Halal Pharmaceuticals Market Size, Share, Trends, Industry Analysis Report: By Drug, Dosage Form, Therapeutic Area, Certification Type, End Users, and Region - Market Forecast, 2025-2034

발행일: 2025년 03월 | 리서치사:

Polaris Market Research | 페이지 정보: 영문 117 Pages | 배송안내 : 1-2일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 할랄 의약품 시장 규모는 2034년까지 2,053억 달러에 달할 것으로 예측됩니다.

할랄 의약품은 이슬람 율법을 준수하고 할랄(금지된) 성분을 포함하지 않는 의약품입니다. 기존 의약품 생산과 할랄 인증 과정에는 유사점도 있지만, 중요한 차이점도 존재합니다. 할랄 의약품의 성분은 식물, 광물, 물, 이슬람 율법에 따라 해체된 동물에서 추출됩니다. 해양 생물은 할랄로 간주되며, 합성 물질은 불순물(나지스)이 없고 사람이 먹어도 안전하다면 허용됩니다.

세금, 보조금, 규제와 같은 정부 정책은 시장 성장에 큰 영향을 미칩니다. 무슬림이 다수인 많은 국가에서 의약품에 할랄 인증을 의무화하는 규제가 할랄 제품에 대한 시장 수요를 촉진하고 있습니다. 또한 할랄 의약품 연구 및 생산에 대한 보조금은 기술 혁신과 투자를 촉진합니다. 할랄 표준을 촉진하는 규제 프레임워크는 할랄 의약품 시장 확대에 더욱 유리한 환경을 조성하고 있습니다.

유기농 및 친환경 제품에 대한 수요 증가는 향후 몇 년 동안 시장 성장을 가속할 것으로 예상되는 주요 시장 동향 중 하나입니다. 이슬람 국가의 경제 환경 개선은 예측 기간 동안 할랄 의약품 시장에 여러 가지 기회를 제공할 것으로 예측됩니다.

할랄 의약품 시장의 주요 특징

의약품별로는 만성질환의 유행과 할랄 인증 의약품에 대한 수요 증가로 인해 처방약 부문이 2024년 가장 큰 시장 점유율을 차지했습니다.

제형별로는 정제 및 캡슐이 2024년 50%의 매출 점유율로 시장을 주도할 것으로 예측됩니다. 이는 주로 편의성, 환자 순응도, 정제/캡슐 투여의 용이성, 복용의 용이성 등에 기인합니다.

북미는 무슬림 인구 증가와 성분 및 조달에 대한 소비자의 인식이 높아짐에 따라 2024년 세계 할랄 의약품 시장의 대부분을 차지할 것으로 예측됩니다.

아시아태평양의 할랄 의약품 시장은 무슬림 인구 증가에 힘입어 예측 기간 동안 가장 빠르게 성장할 것으로 예측됩니다.

Rosemont Pharmaceuticals,EMBIL Pharmaceutical Co.,Noor Vitamins,Bosch Pharmaceuticals,Chemical Company of Malaysia Berhad,Pharmaniaga Bhd. Nutramedica Incorporated,Simpor Pharma Sdn Bhd는 시장의 주요 기업 중 일부입니다.

이 보고서는 세계 할랄 의약품 시장을 조사했으며, 현재 시장 역학에 대한 상세한 고찰과 향후 시장 성장에 대한 분석을 제공합니다.

주요 조사 결과
서론
- 할랄 의약품 시장 평가 : 지역(2020년-2034년)
북미
- 북미 : 의약품별(2020년-2034년)
- 북미 : 제형별(2020년-2034년)
- 북미 : 치료 영역별(2020년-2034년)
- 북미 : 인증 유형별(2020년-2034년)
- 북미 : 최종사용자별(2020년-2034년)
- 미국
- 캐나다
유럽
- 유럽 : 의약품별(2020년-2034년)
- 유럽 : 제형별(2020년-2034년)
- 유럽 : 치료 영역별(2020년-2034년)
- 유럽 : 인증 유형별(2020년-2034년)
- 유럽 : 최종사용자별(2020년-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
아시아태평양
- 아시아태평양 : 의약품별(2020년-2034년)
- 아시아태평양 : 제형별(2020년-2034년)
- 아시아태평양 : 치료 영역별(2020년-2034년)
- 아시아태평양 : 인증 유형별(2020년-2034년)
- 아시아태평양 : 최종사용자별(2020년-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
중동 및 아프리카
- 중동 및 아프리카 : 의약품별(2020년-2034년)
- 중동 및 아프리카 : 제형별(2020년-2034년)
- 중동 및 아프리카 : 치료 영역별(2020년-2034년)
- 중동 및 아프리카 : 인증 유형별(2020년-2034년)
- 중동 및 아프리카 : 최종사용자별(2020년-2034년)
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
라틴아메리카
- 라틴아메리카 : 의약품별(2020년-2034년)
- 라틴아메리카 : 제형별(2020년-2034년)
- 라틴아메리카 : 치료 영역별(2020년-2034년)
- 라틴아메리카 : 인증 유형별(2020년-2034년)
- 라틴아메리카 : 최종사용자별(2020년-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카

제11장 경쟁 구도

확장 및 인수 분석
- 확대
- 인수
파트너십/제휴/합의/공개

제12장 기업 개요

Alkem Laboratories Limited
Amgen Inc.
Bosch Pharmaceuticals
Chemical Company of Malaysia Berhad
EMBIL Pharmaceutical Co.
Noor Vitamins
Nutramedica Incorporated
Pharmaniaga Bhd
Rosemont Pharmaceuticals
Simpor Pharma Sdn Bhd

LSH 25.05.22

The global halal pharmaceuticals market size is expected to reach USD 205.30 billion by 2034, according to a new study by Polaris Market Research. The report "Halal Pharmaceuticals Market Size, Share, Trends, Industry Analysis Report: By Drug, Dosage Form (Injectables, Tablets & Capsules, Orals, Topicals, and Others), Therapeutic Area, Certification Type, End Users, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Halal pharmaceuticals are medications that comply with Islamic law and do not contain any haram (prohibited) components. While there are some similarities between conventional pharmaceutical production and the halal certification process, key differences exist. Halal pharmaceutical ingredients are derived from plants, minerals, water, and animals slaughtered in accordance with Islamic law. Marine creatures are considered halal, and synthetic materials are permitted as long as they are free from impurities (najis) and safe for human consumption.

Government policies, such as taxes, subsidies, and restrictions, significantly influence market growth. In many Muslim-majority countries, regulations mandating halal certifications for pharmaceuticals help drive market demand for compliant products. In addition, subsidies for halal pharmaceutical research and production encourage innovation and investment. Regulatory frameworks promoting halal standards further create a favorable environment for the halal pharmaceuticals market expansion.

The growing demand for organic and environmentally friendly products is one of the major market trends anticipated to drive market development in the coming years. The improving economic climate in Islamic nations is projected to provide several halal pharmaceuticals market opportunities during the forecast period.

Key Highlights of Halal Pharmaceuticals Market

Based on drugs, the prescription drugs segment accounted for the largest market share in 2024, driven by the growing prevalence of chronic illnesses and the rising need for drugs with halal certification.

Based on dosage form, the tablets & capsules segment led the market with a 50% revenue share in 2024. This is primarily attributed to the convenience, patient compliance, and accessibility of tablet and capsule administration among patients.

North America accounted for a significant portion of the global halal medicines market in 2024 due to the region's growing Muslim population and rising consumer awareness of ingredients and sourcing.

The Asia Pacific halal pharmaceuticals market is projected to witness the fastest growth during the forecast period, driven by the significant Muslim population in the region.

Rosemont Pharmaceuticals, EMBIL Pharmaceutical Co., Noor Vitamins, Bosch Pharmaceuticals, Chemical Company of Malaysia Berhad, Pharmaniaga Bhd, Nutramedica Incorporated, and Simpor Pharma Sdn Bhd are a few of the key players in the market.

Polaris Market Research has segmented the global halal pharmaceuticals market report on the basis of drug, dosage form, therapeutic area, certification type, end users, and region:

Halal Pharmaceuticals Market Segmentation

By Drug Outlook (Revenue - USD Billion, 2020-2034)

Over-The-Counter (OTC) drugs
Cosmetics
Prescription Drugs
Nutraceuticals
Medical Devices

By Dosage Form Outlook (Revenue - USD Billion, 2020-2034)

Injectables
Tablets & Capsules
Orals
Topicals
Others

By Therapeutic Area Outlook (Revenue - USD Billion, 2020-2034)

Diabetes
Cardiovascular Diseases
Gastrointestinal Disorders
Anti-Infectives
Respiratory Diseases
Neurological Disorders
Oncology
Others

By Certification Type Outlook (Revenue - USD Billion, 2020-2034)

Halal International Standard
Gulf Standard
Malaysia Standard
Others

By End Users Outlook (Revenue - USD Billion, 2020-2034)

Pharmacies
Hospitals & Clinics
Online Pharmacies
Retailers
Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of the Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Halal Pharmaceuticals Market Insights

4.1. Halal Pharmaceuticals Market - Application Snapshot
4.2. Halal Pharmaceuticals Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Growing Demand for Halal-Certified Goods
  - 4.2.1.2. Increasing Awareness Among Muslim Population
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Regulatory Challenges
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry Among Existing Firms (High)
4.4. PESTEL Analysis
4.5. Halal Pharmaceuticals Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Halal Pharmaceuticals Market, by Drug

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
5.3. Over-The-Counter (OTC) Drugs
- 5.3.1. Global Halal Pharmaceuticals Market, by Over-The-Counter (OTC) Drugs, by Region, 2020-2034 (USD Billion)
5.4. Cosmetics
- 5.4.1. Global Halal Pharmaceuticals Market, by Cosmetics, by Region, 2020-2034 (USD Billion)
5.5. Prescription Drugs
- 5.5.1. Global Halal Pharmaceuticals Market, by Prescription Drugs, by Region, 2020-2034 (USD Billion)
5.6. Nutraceuticals
- 5.6.1. Global Halal Pharmaceuticals Market, by Nutraceuticals, by Region, 2020-2034 (USD Billion)
5.7. Medical Devices
- 5.7.1. Global Halal Pharmaceuticals Market, by Medical Devices, by Region, 2020-2034 (USD Billion)

6. Global Halal Pharmaceuticals Market, by Dosage Form

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
6.3. Injectables
- 6.3.1. Global Halal Pharmaceuticals Market, by Injectables, by Region, 2020-2034 (USD Billion)
6.4. Tablets & Capsules
- 6.4.1. Global Halal Pharmaceuticals Market, by Tablets & Capsules, by Region, 2020-2034 (USD Billion)
6.5. Orals
- 6.5.1. Global Halal Pharmaceuticals Market, by Orals, by Region, 2020-2034 (USD Billion)
6.6. Topicals
- 6.6.1. Global Halal Pharmaceuticals Market, by Topicals, by Region, 2020-2034 (USD Billion)
6.7. Others
- 6.7.1. Global Halal Pharmaceuticals Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Halal Pharmaceuticals Market, by Therapeutic Area

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
7.3. Diabetes
- 7.3.1. Global Halal Pharmaceuticals Market, by Diabetes, by Region, 2020-2034 (USD Billion)
7.4. Cardiovascular Diseases
- 7.4.1. Global Halal Pharmaceuticals Market, by Cardiovascular Diseases, by Region, 2020-2034 (USD Billion)
7.5. Gastrointestinal Diseases
- 7.5.1. Global Halal Pharmaceuticals Market, by Gastrointestinal Diseases, by Region, 2020-2034 (USD Billion)
7.6. Anti-infectives
- 7.6.1. Global Halal Pharmaceuticals Market, by Anti-infectives, by Region, 2020-2034 (USD Billion)
7.7. Respiratory Diseases
- 7.7.1. Global Halal Pharmaceuticals Market, by Respiratory Diseases, by Region, 2020-2034 (USD Billion)
7.8. Neurological Diseases
- 7.8.1. Global Halal Pharmaceuticals Market, by Neurological Diseases, by Region, 2020-2034 (USD Billion)
7.9. Oncology
- 7.9.1. Global Halal Pharmaceuticals Market, by Oncology, by Region, 2020-2034 (USD Billion)
7.10. Others
- 7.10.1. Global Halal Pharmaceuticals Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Halal Pharmaceuticals Market, by Certification Type

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
8.3. Halal International Standard
- 8.3.1. Global Halal Pharmaceuticals Market, by Halal International Standard, by Region, 2020-2034 (USD Billion)
8.4. Gulf Standard
- 8.4.1. Global Halal Pharmaceuticals Market, by Gulf Standard, by Region, 2020-2034 (USD Billion)
8.5. Malaysia Standard
- 8.5.1. Global Halal Pharmaceuticals Market, by Malaysia Standard, by Region, 2020-2034 (USD Billion)
8.6. Others
- 8.6.1. Global Halal Pharmaceuticals Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Halal Pharmaceuticals Market, by End Users

9.1. Key Findings
9.2. Introduction
- 9.2.1. Global Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
9.3. Pharmacies
- 9.3.1. Global Halal Pharmaceuticals Market, by Pharmacies, by Region, 2020-2034 (USD Billion)
9.4. Hospitals & Clinics
- 9.4.1. Global Halal Pharmaceuticals Market, by Hospitals & Clinics, by Region, 2020-2034 (USD Billion)
9.5. Online Pharmacies
- 9.5.1. Global Halal Pharmaceuticals Market, by Online Pharmacies, by Region, 2020-2034 (USD Billion)
9.6. Retailers
- 9.6.1. Global Halal Pharmaceuticals Market, by Retailers, by Region, 2020-2034 (USD Billion)
9.7. Others
- 9.7.1. Global Halal Pharmaceuticals Market, by Others, by Region, 2020-2034 (USD Billion)

10. Global Halal Pharmaceuticals Market, by Geography

10.1. Key Findings
10.2. Introduction
- 10.2.1. Halal Pharmaceuticals Market Assessment, by Geography, 2020-2034 (USD Billion)
10.3. Halal Pharmaceuticals Market - North America
- 10.3.1. North America: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
- 10.3.2. North America: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
- 10.3.3. North America: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.3.4. North America: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
- 10.3.5. North America: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
- 10.3.6. Halal Pharmaceuticals Market - US
  - 10.3.6.1. US: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
  - 10.3.6.2. US: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
  - 10.3.6.3. US: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 10.3.6.4. US: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
  - 10.3.6.5. US: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
- 10.3.7. Halal Pharmaceuticals Market - Canada
  - 10.3.7.1. Canada: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
  - 10.3.7.2. Canada: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
  - 10.3.7.3. Canada: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 10.3.7.4. Canada: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
  - 10.3.7.5. Canada: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
10.4. Halal Pharmaceuticals Market - Europe
- 10.4.1. Europe: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
- 10.4.2. Europe: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
- 10.4.3. Europe: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.4.4. Europe: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
- 10.4.5. Europe: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
- 10.4.6. Halal Pharmaceuticals Market - UK
  - 10.4.6.1. UK: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
  - 10.4.6.2. UK: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
  - 10.4.6.3. UK: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 10.4.6.4. UK: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
  - 10.4.6.5. UK: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
- 10.4.7. Halal Pharmaceuticals Market - France
  - 10.4.7.1. France: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
  - 10.4.7.2. France: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
  - 10.4.7.3. France: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 10.4.7.4. France: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
  - 10.4.7.5. France: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
- 10.4.8. Halal Pharmaceuticals Market - Germany
  - 10.4.8.1. Germany: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
  - 10.4.8.2. Germany: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
  - 10.4.8.3. Germany: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 10.4.8.4. Germany: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
  - 10.4.8.5. Germany: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
- 10.4.9. Halal Pharmaceuticals Market - Italy
  - 10.4.9.1. Italy: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
  - 10.4.9.2. Italy: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
  - 10.4.9.3. Italy: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 10.4.9.4. Italy: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
  - 10.4.9.5. Italy: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
- 10.4.10. Halal Pharmaceuticals Market - Spain
  - 10.4.10.1. Spain: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
  - 10.4.10.2. Spain: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
  - 10.4.10.3. Spain: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 10.4.10.4. Spain: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
  - 10.4.10.5. Spain: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
- 10.4.11. Halal Pharmaceuticals Market - Netherlands
  - 10.4.11.1. Netherlands: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
  - 10.4.11.2. Netherlands: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
  - 10.4.11.3. Netherlands: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 10.4.11.4. Netherlands: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
  - 10.4.11.5. Netherlands: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
- 10.4.12. Halal Pharmaceuticals Market - Russia
  - 10.4.12.1. Russia: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
  - 10.4.12.2. Russia: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
  - 10.4.12.3. Russia: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 10.4.12.4. Russia: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
  - 10.4.12.5. Russia: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
- 10.4.13. Halal Pharmaceuticals Market - Rest of Europe
  - 10.4.13.1. Rest of Europe: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
  - 10.4.13.2. Rest of Europe: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
  - 10.4.13.3. Rest of Europe: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 10.4.13.4. Rest of Europe: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
  - 10.4.13.5. Rest of Europe: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
10.5. Halal Pharmaceuticals Market - Asia Pacific
- 10.5.1. Asia Pacific: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
- 10.5.2. Asia Pacific: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
- 10.5.3. Asia Pacific: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.5.4. Asia Pacific: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
- 10.5.5. Asia Pacific: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
- 10.5.6. Halal Pharmaceuticals Market - China
  - 10.5.6.1. China: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
  - 10.5.6.2. China: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
  - 10.5.6.3. China: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 10.5.6.4. China: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
  - 10.5.6.5. China: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
- 10.5.7. Halal Pharmaceuticals Market - India
  - 10.5.7.1. India: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
  - 10.5.7.2. India: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
  - 10.5.7.3. India: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 10.5.7.4. India: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
  - 10.5.7.5. India: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
- 10.5.8. Halal Pharmaceuticals Market - Malaysia
  - 10.5.8.1. Malaysia: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
  - 10.5.8.2. Malaysia: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
  - 10.5.8.3. Malaysia: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 10.5.8.4. Malaysia: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
  - 10.5.8.5. Malaysia: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
- 10.5.9. Halal Pharmaceuticals Market - Japan
  - 10.5.9.1. Japan: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
  - 10.5.9.2. Japan: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
  - 10.5.9.3. Japan: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 10.5.9.4. Japan: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
  - 10.5.9.5. Japan: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
- 10.5.10. Halal Pharmaceuticals Market - Indonesia
  - 10.5.10.1. Indonesia: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
  - 10.5.10.2. Indonesia: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
  - 10.5.10.3. Indonesia: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 10.5.10.4. Indonesia: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
  - 10.5.10.5. Indonesia: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
- 10.5.11. Halal Pharmaceuticals Market - South Korea
  - 10.5.11.1. South Korea: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
  - 10.5.11.2. South Korea: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
  - 10.5.11.3. South Korea: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 10.5.11.4. South Korea: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
  - 10.5.11.5. South Korea: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
- 10.5.12. Halal Pharmaceuticals Market - Australia
  - 10.5.12.1. Australia: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
  - 10.5.12.2. Australia: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
  - 10.5.12.3. Australia: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 10.5.12.4. Australia: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
  - 10.5.12.5. Australia: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
- 10.5.13. Halal Pharmaceuticals Market - Rest of Asia Pacific
  - 10.5.13.1. Rest of Asia Pacific: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
  - 10.5.13.2. Rest of Asia Pacific: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
  - 10.5.13.3. Rest of Asia Pacific: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 10.5.13.4. Rest of Asia Pacific: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
  - 10.5.13.5. Rest of Asia Pacific: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
10.6. Halal Pharmaceuticals Market - Middle East & Africa
- 10.6.1. Middle East & Africa: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
- 10.6.2. Middle East & Africa: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
- 10.6.3. Middle East & Africa: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.6.4. Middle East & Africa: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
- 10.6.5. Middle East & Africa: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
- 10.6.6. Halal Pharmaceuticals Market - Saudi Arabia
  - 10.6.6.1. Saudi Arabia: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
  - 10.6.6.2. Saudi Arabia: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
  - 10.6.6.3. Saudi Arabia: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 10.6.6.4. Saudi Arabia: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
  - 10.6.6.5. Saudi Arabia: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
- 10.6.7. Halal Pharmaceuticals Market - UAE
  - 10.6.7.1. UAE: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
  - 10.6.7.2. UAE: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
  - 10.6.7.3. UAE: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 10.6.7.4. UAE: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
  - 10.6.7.5. UAE: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
- 10.6.8. Halal Pharmaceuticals Market - Israel
  - 10.6.8.1. Israel: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
  - 10.6.8.2. Israel: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
  - 10.6.8.3. Israel: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 10.6.8.4. Israel: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
  - 10.6.8.5. Israel: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
- 10.6.9. Halal Pharmaceuticals Market - South Africa
  - 10.6.9.1. South Africa: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
  - 10.6.9.2. South Africa: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
  - 10.6.9.3. South Africa: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 10.6.9.4. South Africa: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
  - 10.6.9.5. South Africa: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
- 10.6.10. Halal Pharmaceuticals Market - Rest of Middle East & Africa
  - 10.6.10.1. Rest of Middle East & Africa: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
  - 10.6.10.2. Rest of Middle East & Africa: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
  - 10.6.10.3. Rest of Middle East & Africa: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 10.6.10.4. Rest of Middle East & Africa: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
  - 10.6.10.5. Rest of Middle East & Africa: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
10.7. Halal Pharmaceuticals Market - Latin America
- 10.7.1. Latin America: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
- 10.7.2. Latin America: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
- 10.7.3. Latin America: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 10.7.4. Latin America: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
- 10.7.5. Latin America: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
- 10.7.6. Halal Pharmaceuticals Market - Mexico
  - 10.7.6.1. Mexico: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
  - 10.7.6.2. Mexico: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
  - 10.7.6.3. Mexico: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 10.7.6.4. Mexico: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
  - 10.7.6.5. Mexico: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
- 10.7.7. Halal Pharmaceuticals Market - Brazil
  - 10.7.7.1. Brazil: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
  - 10.7.7.2. Brazil: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
  - 10.7.7.3. Brazil: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 10.7.7.4. Brazil: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
  - 10.7.7.5. Brazil: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
- 10.7.8. Halal Pharmaceuticals Market - Argentina
  - 10.7.8.1. Argentina: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
  - 10.7.8.2. Argentina: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
  - 10.7.8.3. Argentina: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 10.7.8.4. Argentina: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
  - 10.7.8.5. Argentina: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
- 10.7.9. Halal Pharmaceuticals Market - Rest of Latin America
  - 10.7.9.1. Rest of Latin America: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
  - 10.7.9.2. Rest of Latin America: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
  - 10.7.9.3. Rest of Latin America: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 10.7.9.4. Rest of Latin America: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
  - 10.7.9.5. Rest of Latin America: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)

11. Competitive Landscape

11.1. Expansion and Acquisition Analysis
- 11.1.1. Expansion
- 11.1.2. Acquisitions
11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

12.1. Alkem Laboratories Limited
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Benchmarking
- 12.1.4. Recent Development
12.2. Amgen Inc.
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Benchmarking
- 12.2.4. Recent Development
12.3. Bosch Pharmaceuticals
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Benchmarking
- 12.3.4. Recent Development
12.4. Chemical Company of Malaysia Berhad
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Benchmarking
- 12.4.4. Recent Development
12.5. EMBIL Pharmaceutical Co.
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Benchmarking
- 12.5.4. Recent Development
12.6. Noor Vitamins
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Benchmarking
- 12.6.4. Recent Development
12.7. Nutramedica Incorporated
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Benchmarking
- 12.7.4. Recent Development
12.8. Pharmaniaga Bhd
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Benchmarking
- 12.8.4. Recent Development
12.9. Rosemont Pharmaceuticals
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Benchmarking
- 12.9.4. Recent Development
12.10. Simpor Pharma Sdn Bhd
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Benchmarking
- 12.10.4. Recent Development

02-2025-2992
(주말 및 공휴일 제외)

라이선스 / 가격

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,250

￦ 6,151,000

PDF (Multi User License)

PDF 보고서를 동일 기업 20명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,250

￦ 7,598,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,250

￦ 9,046,000

※ 부가세 별도

검색

F A Q

세계의 할랄 의약품 시장 : 시장 규모, 점유율, 동향, 산업 분석 : 의약품별, 제형별, 치료 영역별, 인증 유형별, 최종사용자별, 지역별 - 시장 예측(2025-2034년)

Halal Pharmaceuticals Market Size, Share, Trends, Industry Analysis Report: By Drug, Dosage Form, Therapeutic Area, Certification Type, End Users, and Region - Market Forecast, 2025-2034

목차

제1장 서론

제2장 주요 요약

제3장 조사 방법

제4장 세계의 할랄 의약품 시장 인사이트

제5장 세계의 할랄 의약품 시장 : 의약품별

제6장 세계의 할랄 의약품 시장 : 제형별

제7장 세계의 할랄 의약품 시장 : 치료 영역별

제8장 세계의 할랄 의약품 시장 : 인증 유형별

제9장 세계의 할랄 의약품 시장 : 최종사용자별

제10장 세계의 할랄 의약품 시장 : 지역